John Harris, MD, PhD: Developments in JAK Inhibitors for Vitiligo

Dr. Harris discusses the recent research milestones achieved in the JAK inhibitor revolution for vitiligo and what future developments can be expected.

More Maui Derm 2023 Video Coverage

Dr. Chilukuri recaps his “What’s my Treatment?” presentation delivered at Maui Derm 2023.
Dr. Glaser discusses exciting new toxins and fillers to look out for in the coming year.
Dr. Werschler provides an overview of the cosmetic dermatology sessions and workshops provided at Maui Derm 2023.
Dr. Friedlander summarizes the most notable additions to the pediatric dermatology literature from the past year.
Dr. Chovatiya recaps his session from Maui Derm 2023, in which he took a deep dive into eczema, spongiotic dermatitis, and atopic dermatitis.
Dr. Cohen discusses the 1726 nm laser for the treatment of acne.

Dr. Cohen discusses his strategies for heavy laser resurfacing for a variety of cosmetic applications.

Dr. Gold recaps his presentation from the “Lasers, Lights, Radiofrequency, Photodynamic Therapy and More” session from Maui Derm 2023.
Dr. Rosen discusses new methods for the treatment and prevention of actinic keratoses, including nicotinamide and a painless protocol for photodynamic therapy.
Dr. Rosen recaps his New Drugs and Devices session delivered at Maui Derm 2023.

Dr. Kircik provides an overview of the current landscape of JAK inhibitors used by dermatologists.

Dr. Siegel discusses his Maui Derm 2023 presentation, “How To Maximize Your Billing Effectiveness In The Era of Dwindling Reimbursements and ICD-10
Dr. Shamban recaps her Maui Derm 2023 presentation delivered during the, “What’s my Treatment?” session, in which she reported three notable cases encountered at her
Dr. Eichenfield recaps his Maui Derm 2023 presentation, in which he discusses developments in pediatric acne.
Dr. Blauvelt discusses his presentation at Maui Derm 2023, in which he compares new safety data for JAK inhibitors in atopic dermatitis treatment with data
Dr. Zirwas reviews new advancements in systemics for atopic dermatitis including JAK inhibitors and the current black box warnings for these treatments.
Dr. Stein Gold discusses her presentation at Maui Derm 2023 which focused on new TYK2 inhibitors for the treatment of plaque psoriasis, along with other
Dr. Stein Gold discusses various misconceptions of localized psoriasis and stresses that topical therapy remains the mainstay of treatment for this disease.
Dr. Kaufmann reviews his session regarding coding and reimbursement issues at the end of 2022 with hopes to better keep up with inflation in 2023.
Dr. Bhatia reviews an array of new therapies discussed during his New Drugs and Therapies presentation at Maui Derm 2023.
Dr. Bhatia gives an overview of the utilization of JAK inhibitors in diseases such as hidradenitis suppurativa, vitiligo, alopecia areata, psoriasis, and atopic dermatitis.
Dr. Bhatia details the recent approval of Ritlecitinib which is launching soon for the treatment of alopecia areata.
Dr. Zirwas provides the main takeaways from his contact dermatitis update presentation delivered at Maui Derm 2023, including new insights into treating irritant hand dermatitis.
Dr. Eichenfield discusses his presentation from Maui Derm 2023 that focused on developments in pediatric acne.

Top Stories of 2022–2023 presented by Hensin Tsao, MD, PhD Dr. Tsao guided attendees through main takeaways from the top research in dermatology from the